According to a new report by Polaris Market Research, the global prefilled syringes market was valued at USD 9.09 billion in 2025 and is projected to reach USD 26.81 billion by 2034, expanding at a CAGR of 12.8% over the forecast period. Growth is underpinned by rising demand for biologics and biosimilars, expanding self-administration of injectable therapies, and accelerating adoption of patient-centric, safety-engineered drug delivery devices across key end-use industries.
Prefilled syringe manufacturers play a critical role in the pharmaceutical and healthcare industry by supporting convenient, accurate, and safer drug delivery. Growing demand for biologics, self-administration devices, and injectable therapies is driving innovation in syringe design and production. Manufacturers are increasingly focusing on advanced materials, safety features, and large-scale production capabilities.
What Is Driving Prefilled Syringes Market Growth?
Demand is climbing as the growing burden of chronic disease converges with a rapid expansion in biologic and biosimilar drug pipelines. Manufacturers and end users are prioritizing dose precision and contamination control, pushing prefilled syringe adoption across hospitals, clinics, and home healthcare settings. Polaris analysts note that the International Diabetes Federation's estimate of roughly 537 million adults living with diabetes underscores the scale of reliance on injectable, insulin-based therapies, positioning the segment for sustained double-digit growth through 2034, with pharmaceutical and biotechnology companies emerging as the largest revenue contributor and contract research and manufacturing organizations posting the fastest incremental gains.
Key Trends Shaping the Prefilled Syringes Industry
Patient-Centric Device Innovation
Auto-disable syringes and needle-free formats are becoming more common as manufacturers respond to the broader healthcare shift toward self-administration, particularly for hormone therapies and rheumatoid arthritis treatments, supporting overall industry trends toward safer, easier-to-use injectable drug delivery.
Sustainability and Material Innovation
Environmental pressure is prompting a shift toward biodegradable polymers and recyclable components. Industry survey data indicates that a majority of healthcare-plastics stakeholders now treat sustainability as a critical product-development factor, a dynamic reshaping the regulatory landscape in markets such as the European Union.
Biologics-Driven Investment and Capacity Expansion
Rising biologics and biosimilar volumes are prompting capacity investment across the supply chain, from glass and polymer component makers to fill-finish manufacturers, reinforcing a favorable market outlook and intensifying competitive landscape activity among leading device makers.
Market Segmentation: Breaking Down the Prefilled Syringes Market
Polaris segments the prefilled syringes market by material, closing system, product, design, end user, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.
By Material
The glass segment led the market in 2025, accounting for 68.1% of revenue, on the strength of its superior chemical resistance and low risk of drug interaction for sensitive biologics. The plastic segment is projected to expand at the fastest CAGR of 14.3% through 2034 as lightweight, shatter-resistant polymer syringes gain traction in high-volume and emergency-care settings.
By Closing System
Staked needle systems remain the dominant closing-system category, holding a 57.0% share in 2025 on the back of their integrated, ready-to-use design that lowers contamination risk in mass immunization programs. Luer lock form systems are gaining share fastest, at a 12.8% CAGR, as their secure connection mechanism suits high-pressure injection of viscous biologics such as monoclonal antibodies, signaling where near-term demand around secure-connection syringe formats is shifting.
By End User
Pharmaceutical and biotechnology companies captured the largest share in 2025, at 65.0%, reflecting their central role in developing and distributing biologics, vaccines, and injectable therapies. Contract research and manufacturing organizations are expected to post the strongest incremental growth, at a 13.3% CAGR, reflecting regulatory tailwinds toward outsourced, scalable fill-finish capacity.
By Design
On a design basis, single-chamber syringes hold the largest revenue share at 74.0%, owing to their cost-effectiveness across vaccines, anticoagulants, and biologics. Double-chamber syringes are forecast to outpace the broader market at a 10.9% CAGR as they enable point-of-care reconstitution of lyophilized drugs and their diluents, easing integration into complex biologic treatment regimens.
Regional Outlook: Where Is the Prefilled Syringes Market Growing Fastest?
Europe led the market in 2025 on the back of advanced healthcare infrastructure, a strong pharmaceutical manufacturing base, and stringent drug-safety regulation, while Asia Pacific is expected to post the fastest CAGR through 2034, driven by expanding healthcare access and rising government spending on drug delivery modernization. Within Europe, Germany remains among the largest single markets alongside the UK and France; within Asia Pacific, China is a primary growth engine alongside Japan and India. North America rounds out the top three, supported by continued domestic manufacturing investment and biologics supply-chain expansion.
??????? ??? ???????? ????????????? ?????? ???? :
https://www.polarismarketresearch.com/industry-analysis/prefilled-syringes-market
Competitive Landscape: Leading Prefilled Syringes Companies
Key players profiled in the report include Becton, Dickinson and Company (BD), Gerresheimer AG, Schott AG, West Pharmaceutical Services, and AptarGroup, Inc., who are focusing on capacity expansion, product launches, and strategic partnerships to strengthen market position across the glass and staked-needle segments outlined above. Recent moves include BD's announced USD 110 million investment in U.S. prefillable syringe manufacturing capacity and West Pharmaceutical Services' commercial launch of its Synchrony prefillable syringe system, both aimed at deepening share in North America and Europe.
Why It Matters for Buyers Evaluating Market Entry
For stakeholders researching the prefilled syringes market report, this study benchmarks market share, segment-level pricing, and forecast data — by material, closing system, product, design, end user, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking components and accessories as a growth adjacency.
More Trending Latest Reports By Polaris Market Research:
automated-teller-machine-atm-market
global-organic-skin-care-market
carbon-accounting-software-market
recruitment-process-outsourcing-market
Comments